Pular para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Título
Autor
Assunto
Número de Chamada
ISBN/ISSN
Tag
Buscar
Avançada
Lack of minority K65R-resistan...
Citar
Enviar por SMS
Enviar por e-mail
Imprimir
Exportar registro
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Link permanente
Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.
Detalhes bibliográficos
Principais autores:
McCormick, A
,
Goodall, R
,
Joyce, A
,
Ndembi, N
,
Chirara, M
,
Katundu, P
,
Walker, S
,
Yirrell, D
,
Gilks, C
,
Pillay, D
Formato:
Journal article
Idioma:
English
Publicado em:
2010
Itens
Descrição
Registros relacionados
Registro fonte
Registros relacionados
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
por: Ndembi, N, et al.
Publicado em: (2010)
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
por: Green, H, et al.
Publicado em: (2007)
Brain antioxidants and hippocampal microanatomical alterations following the administration of Efavirenz/Lamivudine/Tenofovir disoproxil fumarate and Lamivudine/Nevirapine/Zidovudine in adult male Wistar rats
por: Innocent A. Edagha, et al.
Publicado em: (2022-06-01)
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
por: Gibb, D, et al.
Publicado em: (2002)
Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
por: Yu Cong, et al.
Publicado em: (2016-01-01)